The experimental drug Tykerb has been shown to reduce the spread of breast cancer when combined with Xeloda, in a study led by Dr. Charles Geyer, Jr.

The combination of the 2 drugs almost doubled the delay when compared to trials done on Xeloda alone.

Tykerb belongs to a class of drugs that are more specifically-targeted and kill less…